Effects of low-intensity ultrasound opening the blood-brain barrier on Alzheimer's disease—a mini review

Effects of low-intensity ultrasound opening the blood-brain barrier on Alzheimer's disease—a mini review

Due to the complex pathological mechanisms of Alzheimer's disease (AD), its treatment remains a challenge. One of the major difficulties in treating AD is the difficulty for drugs to cross the blood–brain barrier (BBB). Low-intensity ultrasound (LIUS) is a novel type of ultrasound with neuromod...

Полное описание

Библиографические подробности
Главные авторы:	Mengmeng Zhou, Xuanhao Fu, Boyuan Ma, Ziyu Chen, Yuelin Cheng, Linyan Liu, Shunli Kan, Xinyan Zhao, Sa Feng, Zehua Jiang, Rusen Zhu
Формат:	Статья
Язык:	English
Опубликовано:	Frontiers Media S.A. 2023-11-01
Серии:	Frontiers in Neurology
Предметы:	low-intensity ultrasound blood-brain barrier opening Alzheimer's disease β-amyloid tau
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1274642/full

Схожие документы

Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges
по: Iram Iqbal, и др.
Опубликовано: (2024-06-01)

Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
по: Kaden L. Nystuen, и др.
Опубликовано: (2024-01-01)

Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
по: Marcos Pais, и др.
Опубликовано: (2020-01-01)

GSK3 and Alzheimer's disease: facts & fiction …
по: Fred eVanleuven
Опубликовано: (2011-08-01)

The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
по: Christina E. Murray, и др.
Опубликовано: (2018-07-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
по: Md. Sahab Uddin, и др.
Опубликовано: (2018-01-01)

β-Amyloid Plaque Reduction in the Hippocampus After Focused Ultrasound-Induced Blood–Brain Barrier Opening in Alzheimer’s Disease
по: Pierre-François D’Haese, и др.
Опубликовано: (2020-10-01)

Pathological correlates of impaired self-awareness of memory function in Alzheimer’s disease
по: Geoffroy Gagliardi, и др.
Опубликовано: (2021-06-01)

T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease
по: Junjian Zeng, и др.
Опубликовано: (2024-04-01)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
по: Jean-Marie eSontag, и др.
Опубликовано: (2014-03-01)

Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
по: Cassia R. Overk, и др.
Опубликовано: (2009-09-01)

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
по: Yuanxin Zhao, и др.
Опубликовано: (2022-07-01)

Evaluating Circadian Dysfunction in Mouse Models of Alzheimer’s Disease: Where Do We Stand?
по: Patrick W. Sheehan, и др.
Опубликовано: (2020-07-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
по: Castillo-Carranza DL, и др.
Опубликовано: (2013-12-01)

The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome
по: Yvonne S. Davidson, и др.
Опубликовано: (2018-07-01)

Focused ultrasound therapy for Alzheimer’s disease: exploring the potential for targeted amyloid disaggregation
по: Kurt Scott, и др.
Опубликовано: (2024-08-01)

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
по: Stephanie R. Oatman, и др.
Опубликовано: (2023-01-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
по: Daniel Lamontagne-Kam, и др.
Опубликовано: (2023-07-01)

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
по: Azadeh Firouzian, и др.
Опубликовано: (2018-03-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
по: Juanjuan Zhao, и др.
Опубликовано: (2017-07-01)

Synaptic activity and Alzheimer’s disease: a critical update
по: Davide eTampellini
Опубликовано: (2015-11-01)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
по: Yuehua Huang, и др.
Опубликовано: (2022-09-01)

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
по: Linda J. Van Eldik, и др.
Опубликовано: (2024-10-01)

Dityrosine cross-linking and its potential roles in Alzheimer’s disease
по: Mahmoud B. Maina, и др.
Опубликовано: (2023-03-01)

The emerging double-edged sword role of exosomes in Alzheimer’s disease
по: Tao Liang, и др.
Опубликовано: (2023-06-01)

Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease
по: Erin E. Congdon
Опубликовано: (2018-06-01)

Time between milestone events in the Alzheimer's disease amyloid cascade
по: Philip S. Insel, и др.
Опубликовано: (2021-02-01)

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
по: Donovan A. McGrowder, и др.
Опубликовано: (2021-02-01)

Is later-life depression a risk factor for Alzheimer’s disease or a prodromal symptom: a study using post-mortem human brain tissue?
по: Lindsey I. Sinclair, и др.
Опубликовано: (2023-09-01)

Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease
по: Javier Arranz, и др.
Опубликовано: (2024-06-01)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
по: Josef Marksteiner, и др.
Опубликовано: (2022-09-01)

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
по: Eliasz Engelhardt, и др.
Опубликовано: (2024-12-01)

Mouse Models of Alzheimer’s Disease
по: Miyabishara Yokoyama, и др.
Опубликовано: (2022-06-01)

Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer’s Disease
по: Cherie Strikwerda-Brown, и др.
Опубликовано: (2023-01-01)

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
по: Marcella Catania, и др.
Опубликовано: (2019-11-01)

Curcuminoids and resveratrol as anti-Alzheimer agents
по: Oliver B. Villaflores, и др.
Опубликовано: (2012-12-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
по: Niklas Mattsson‐Carlgren, и др.
Опубликовано: (2021-05-01)

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
по: Evgenia Salta, и др.
Опубликовано: (2016-08-01)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
по: Rola Ismail, и др.
Опубликовано: (2020-05-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
по: Hong-Qi Yang, и др.
Опубликовано: (2012-10-01)